We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

This paper describes the eccentricity, amplitude, phase shift, angular momentum, polarization, radial path, and orbital ...

Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial SLNB is a well-tolerated, minimally invasive procedure with low rates of ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Analyst/Investor Day November 11, 2025 3:00 AM ESTCompany ParticipantsBenedicte Fasmer - President & CEOTorbjorn Wist ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...